Abstract:Aim The aim was to evaluate the impact of metabolic syndrome (MS), MS individual components and 32 kinds of MS specific component combinations on all-cause mortality risk in a fixed cohort of MJ check-up population. Methods We observed the events of death in a fixed cohort, where the population was composed of 45,542 individuals aged 35–74 who were examined at MJ Health check-up Center in 1997 as baseline examination, and were followed up to 2005. Median duration of follow-up was 7.44 years. MS was defined according to the National Cholesterol Educational Program (the revised NCEP-ATPIII for Asian in 2004), the prevalence of MS was standardized according to China’s fifth census data. We constructed common Cox regression model, simultaneously adjusting the classic risk factors (such as age, sex, smoking, alcohol drinking, physical activity, family history, etc.) to examine the relationship between MS, MS individual components and 32 kinds of MS specific component combinations on the occurrence of death with the fixed cohort. Results The standardized prevalence of MS was 29.75% (male: 30.36%, female: 29.51%). There were 1,749 persons who died during the median 7.44-years follow-up, the mortality rate was 46 per 10,000 person years. The mortality rates were 71 and 35 per 10,000 person years for those with and without MS, respectively. After adjustment for age, sex and classical risk factors, compared with subjects without MS, the hazard ratio of all-cause mortality was 1.26 (95% CI: 1.14–1.40). The all-cause mortality were more highly significant than other combinations (P <0.05) when the following combinations exist: “elevated blood pressure”, “elevated fasting plasma glucose + low high-density lipoprotein cholesterol”, “elevated blood pressure + elevated triglyceride + elevated fasting plasma glucose”, “elevated fasting plasma glucose + low high-density lipoprotein cholesterol + elevated blood pressure + elevated triglyceride”. After adjusting age, sex and classical risk factors, the HRs for those with 0 to 5 components were 1, 1.22, 1.25, 1.33, 1.66, and 1.92, respectively. There was a significant dose-response relationship (P for liner trend <0.001) between the number of MS components and the risk of all-cause mortality in the overall fixed cohort sample. Conclusion In a large scale middle-aged Taiwan check-up population, MS may be associated with a much higher risk for all-cause mortality. These results may underline the fact that MS is a non-homogeneous syndrome and have a significant impact on detecting high-risk individuals suffering from metabolic disorders for preventing and controlling death.

The Associations of Metabolic Syndrome with Incident Hypertension, Type 2 Diabetes Mellitus and Chronic Kidney Disease: a Cohort Study

Relationship between Metabolic Syndrome and Chronic Kidney Disease

GW26-e4604 The Cohort Study on Prediction of Incidence of Hypertension, type 2 Diabetes and Chronic Kidney Disease by Metabolic Syndrome

Metabolic Syndrome and the Development of Chronic Kidney Disease among 118 924 Non‐diabetic Taiwanese in a Retrospective Cohort

Association between metabolic syndrome and kidney cancer risk: a prospective cohort study

Effects of Metabolic Syndrome and Its Components on Chronic Kidney Disease and Renal Function: A Two-Sample Mendelian Randomization Study

The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults

Metabolic Syndrome and Chronic Kidney Disease in General Chinese Adults: Results from the 2007-08 China National Diabetes and Metabolic Disorders Study

Metabolic Syndrome and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older.

Metabolic Syndrome Without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study

Both Insulin Resistance and Metabolic Syndrome Accelerate the Progression of Chronic Kidney Disease among Chinese Adults: Results from a 3-Year Follow-Up Study

The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project

Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis

Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults

Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus

Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study

A prospective study on association of metabolic syndrome with cardiovascular disease

Metabolic syndrome as a risk factor for the development of kidney dysfunction: a meta-analysis of observational cohort studies

The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome

The Effect of Metabolic Syndrome and Its Individual Components on Renal Function: A Meta-Analysis